Drug Discovery

The microbiome
#Drug discovery #Gut microbiome #Microbiome #Precision medicine

The microbiome in precision medicine

Listen to this article on the DDW Podcast: An industry overview of the role of the microbiome in precision medicine, and its interplay with research tools, diagnostics, and therapeutic development. By Katie Gillette, Senior Project Leader, Eliza French, Analyst, and Graham Friedman, Analyst, DeciBio. Read More

#Exclusive Content #Trends & Analysis

Paediatric medicine concept
#Drug development #EMA #FDA #Paediatrics #Regulatory

What recent paediatric guidelines mean for drug developers 

Justin Hay, Senior Director, Amy Cheung Senior Director of Integrated Drug Development, and Patrick Loebs Director, at Certara, examine recent changes in paediatric guidelines and how they affect drug development projects.   It has been a very busy period recently for paediatric drug development with the release of many guidance… Read More

#Regulatory

#Acquisition #Biopharma #Biotechnology #CDMO #Cell and gene therapy #Cold chain #Drug development #GSK #Pfizer #Regulatory #Supply chain

New podcast: A business case for drug discovery

This is the latest episode of the free DDW narrated podcast, “A business case for drug discovery”, which covers three articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “A deal in the making”, “Why project management… Read More

#News

Drug discovery
#Drug discovery #Medicines Discovery Catapult (MDC)

New podcast on bridging the gaps in drug discovery

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this latest episode, DDW’s Megan Thomas is in conversation with… Read More

#News

AI drug discovery
#AI / data analytics / healthtech / informatics #Drug discovery #Funding #Investment #Recursion

Nvidia invests $50 million into Recursion for drug AI 

Recursion, a clinical stage company decoding biology to industrialise drug discovery, has announced a $50 million investment by NVIDIA, which was executed as a private investment in public equity (PIPE).   Recursion also announced plans to accelerate development of its AI foundation models for biology and chemistry,… Read More

#News

microRNA
#Drug development #Elegen #Events #mRNA #mRNA-based vaccines #Webinar

Webinar: The breakthroughs in mRNA drug discovery

Hosted by DDW and sponsored by Elegen, “Where are the breakthroughs in mRNA drug discovery and development?” will be free to attend on July 19 at 8AM PDT / 11AM EST / 4PM BST / 5PM CET. Join this free webinar to learn about the opportunities in… Read More

Webinar date:
Brought to you by The Jackson Laboratory
#News

#AMR #Covid-19 #Diabetes #Drug development #FDA #Genetics / genomics #Influenza #Parasitic disease

New DDW Highlights podcast: 10 July 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  It’s been a fascinating week in drug discovery, as AstraZeneca announced that its Phase III trial… Read More

#News

#AMR #Covid-19 #Diabetes #Drug development #FDA #Genetics / genomics #Influenza #Parasitic disease

This week in drug discovery (3-7 July)  

News round-up for 3-7 July by DDW Digital Content Editor Diana Spencer. It’s been a fascinating week in drug discovery, as AstraZeneca announced that its Phase III trial of datopotamab deruxtecan did not meet its second primary endpoint and saw an 8% drop in its stock… Read More

#News

Gene editing
#bit bio #CRISPR #Drug discovery #Stem cells #Synthetic biology #Synthetic DNA

Synthetic biology: Impacting drug discovery

Listen to this article on the DDW Podcast: Mark Kotter, Founder and CEO of bit.bio, talks with Reece Armstrong about different approaches to synthetic biology and its applications in programming stem cells into mature, functional human cells for drug discovery and the creation of next… Read More

#Exclusive Content

Cone snails
#Drug development #Drug discovery #University of Queensland

Cone snail venom discovery opens up new leads for drugs

Researchers have reared deadly cone snails in a laboratory aquarium for the first time, uncovering new venoms for drug development. Professor Richard Lewis, Dr Aymeric Rogalski and Dr Himaya Siddhihalu Wickrama Hewage from University of Queensland’s (UQ) Institute for Molecular Bioscience study venoms as therapeutics, and… Read More

#News

Sleeping sickness parasite
#Drug discovery #Novartis #Parasitic disease #University of Glasgow

Compound discovery has breakthrough potential for parasitic disease

Scientists have discovered a new class of compound that is potentially active against trypanosome parasites that cause human African trypanosomiasis (or sleeping sickness) and Chagas disease. The findings – led by researchers at the University of Glasgow and Novartis Global Health (formerly Novartis Institutes for Tropical… Read More

#News

Oncology Research Concept
#Cancer research #Drug discovery #Haematology #Oncology

Q&A with Mark Garner: The golden age of cancer research  

Mark Garner, PhD., Global Cancer Segment Market Manager at Agilent Technologies, recently sat down with DDW Editor Reece Armstrong to tell us about the developments in the ‘golden age’ of cancer research.  RA: Please can you tell us a bit more about your role at Agilent?… Read More

#Exclusive Content

Genetic engineering concept with medication capsule with human brain diagram at programming language background
#Antibody #Drug discovery #Immuno-oncology #Therapeutic Antibodies #Therapeutics

DDW Summer 2023 issue out now

The Summer 2023 issue of Drug Discovery World Magazine is out now and includes an exclusive guide on Therapeutic Antibodies.  Featuring a Therapeutic Spotlight on Immuno-oncology, the magazine is available to download free here and read for free on the DDW App.  You can also… Read More

#News

#Drug development #Elegen #Events #mRNA #mRNA-based vaccines #Webinar

What does the future hold for mRNA therapeutics? Register now

Hosted by DDW and sponsored by Elegen, “Where are the breakthroughs in mRNA drug discovery and development?” will be free to attend on July 19 at 8AM PDT / 11AM EST / 4PM BST / 5PM CET. Join this free webinar to learn about the opportunities in… Read More

Webinar date:
Brought to you by The Jackson Laboratory
#News